WMB
58
3
ZION
49
9
MET
58
2
SNA
56
3
FOXA
67
5
UAL
73
3
FMC
23
7
AMAT
33
3
SIG
52
5
NOV
45
2
DE
49
3
EXPE
83
8
UA
48
6
XRX
48
2
EXR
42
5
ILMN
31
4
NKE
36
2
ROK
46
3
EQR
33
6
ADBE
50
3
WMB
58
3
ZION
49
9
MET
58
2
SNA
56
3
FOXA
67
5
UAL
73
3
FMC
23
7
AMAT
33
3
SIG
52
5
NOV
45
2
DE
49
3
EXPE
83
8
UA
48
6
XRX
48
2
EXR
42
5
ILMN
31
4
NKE
36
2
ROK
46
3
EQR
33
6
ADBE
50
3
Financhill
Back

Myriad Genetics Quote, Financials, Valuation and Earnings

The Trump Nuclear MEGA-Boom!

Here's why nuclear stocks are expected to skyrocket under Trump's second term.
Sell
21

MYGN
Myriad Genetics

Last Price:
$13.35
Seasonality Move:
14.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

Myriad Genetics Price Quote

$13.35
-0.01 (1.37%)
(Updated: December 21, 2024 at 5:38 AM ET)

Myriad Genetics Key Stats

Sell
21
Myriad Genetics (MYGN) is a Sell
Day range:
$13.04 - $13.56
52-week range:
$12.87 - $29.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.45
P/B ratio:
1.66%
Volume:
3.8M
Avg. volume:
1.1M
1-year change:
-34.25%
Market cap:
$1.2B
Revenue:
$753.2M
EPS:
$-1.3

How Much Does Myriad Genetics Make?

Data Unavailable

Is Myriad Genetics Growing As A Company?

Data Unavailable

Myriad Genetics Stock Price Performance

  • Did Myriad Genetics Stock Go Up Last Month?
    Myriad Genetics share price went down by -12.68% last month
  • Did MYGN's Share Price Rise Over The Last Year?
    MYGN share price fell by -34.25% over the past 1 year

What Is Myriad Genetics 52-Week High & Low?

Myriad Genetics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Myriad Genetics?

Data Unavailable

Is Myriad Genetics Cash Flow Positive?

Data Unavailable

Myriad Genetics Return On Invested Capital

Data Unavailable

Myriad Genetics Earnings Date & Stock Price

Myriad Genetics Competitors

  • Who Are Myriad Genetics's Competitors?
    Below is a list of companies who compete with Myriad Genetics or are related in some way:
    • Boston Scientific Corp (BSX)
    • Perspective Therapeutics Inc (CATX)
    • Globus Medical Inc (GMED)
    • Haemonetics Corp (HAE)
    • ResMed Inc (RMD)

Myriad Genetics Dividend Yield

Data Unavailable

Myriad Genetics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 211.04%
Revenue: 11.15% 1.19%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 24.08
Upside from Last Price: 80.26%

Major Shareholders

Data Unavailable